Oxidative stress and diabetic retinopathy: development and treatment

被引:198
作者
Calderon, G. D. [1 ]
Juarez, O. H. [2 ,3 ]
Hernandez, G. E. [2 ]
Punzo, S. M. [2 ]
De la Cruz, Z. D. [3 ]
机构
[1] Natl Inst Pediat, Lab Neurochem, Mexico City, DF, Mexico
[2] Natl Inst Pediat, Lab Pharmacol, Av Iman 1,3er Piso, Mexico City 04530, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Pharmacol, Fac Med, Mexico City, DF, Mexico
关键词
NITRIC-OXIDE; APOPTOSIS; EXPRESSION; HYPERGLYCEMIA; MITOCHONDRIA; DAMAGE; RETINA; CELLS; ANTIOXIDANTS; DYSFUNCTION;
D O I
10.1038/eye.2017.64
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Diabetic retinopathy (DR) is the most common microvascular complication in diabetic patients and one of the main causes of acquired blindness in the world. From the 90s until date, the incidence of this complication has increased. Reactive oxygen species (ROS) is a free radical with impaired electron that usually participates in the redox mechanisms of some body molecules such as enzymes, proteins, and so on. In normal biological conditions, ROS is maintained in equilibrium, however its overproduction can lead to biological process called oxidative stress and this is considered the main pathogenesis of DR. The retina is susceptible to ROS because of high-energy demands and exposure to light. When the balance is broken, ROS produces retinal cell injury by interacting with the cellular components. This article describes the possible role of oxidative stress in the development of DR and proposes some treatment options based on its stages. The review of the topic shows that blindness caused by DR can be avoided by early detection and timely treatment.
引用
收藏
页码:1122 / 1130
页数:9
相关论文
共 76 条
  • [1] High-Mobility Group Box-1 Induces Decreased Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Retina
    Abu El-Asrar, Ahmed M.
    Nawaz, Mohd Imtiaz
    Siddiquei, Mohammad Mairaj
    Al-Kharashi, Abdullah S.
    Kangave, Dustan
    Mohammad, Ghulam
    [J]. MEDIATORS OF INFLAMMATION, 2013, 2013
  • [2] Production of reactive oxygen species in brain mitochondria: Contribution by electron transport chain and non-electron transport chain sources
    Adam-Vizi, V
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (9-10) : 1140 - 1149
  • [3] [Anonymous], 1998, Clinical trials in ophthalmology: a summary and practice guide
  • [4] Dopamine Deficiency Contributes to Early Visual Dysfunction in a Rodent Model of Type 1 Diabetes
    Aung, Moe H.
    Park, Han Na
    Han, Moon K.
    Obertone, Tracy S.
    Abey, Jane
    Aseem, Fazila
    Thule, Peter M.
    Iuvone, P. Michael
    Pardue, Machelle T.
    [J]. JOURNAL OF NEUROSCIENCE, 2014, 34 (03) : 726 - 736
  • [5] Progressive changes in diabetics and their management
    Aylward, GW
    [J]. EYE, 2005, 19 (10) : 1115 - 1118
  • [6] Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
    Bai, Yang
    Cui, Wenpeng
    Xin, Ying
    Miao, Xiao
    Barati, Michelle T.
    Zhang, Chi
    Chen, Qiang
    Tan, Yi
    Cui, Taixing
    Zheng, Yang
    Cai, Lu
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 57 : 82 - 95
  • [7] Diabetic Macular Edema: Pathogenesis and Treatment
    Bhagat, Neelakshi
    Grigorian, Ruben A.
    Tutela, Arthur
    Zarbin, Marco A.
    [J]. SURVEY OF OPHTHALMOLOGY, 2009, 54 (01) : 1 - 32
  • [8] Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
    Bolinger, Mark T.
    Antonetti, David A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09)
  • [9] The UCP1 -3826A/G Polymorphism Is Associated with Diabetic Retinopathy and Increased UCP1 and MnSOD2 Gene Expression in Human Retina
    Brondani, Leticia A.
    de Souza, Bianca M.
    Duarte, Guilherme C. K.
    Kliemann, Lucia M.
    Esteves, Jorge F.
    Marcon, Alexandre S.
    Gross, Jorge L.
    Canani, Luis H.
    Crispim, Daisy
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (12) : 7449 - 7457
  • [10] The pathobiology of diabetic complications - A unifying mechanism
    Brownlee, M
    [J]. DIABETES, 2005, 54 (06) : 1615 - 1625